Clinical Trial Update: An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing Flutiform pMDI to Fluticasone/Formoterol DPI in adolescents and adults with persistent asthma; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Asthma Bronchiale

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)
• Fluticasone propionate/formoterol (fluticasone propionate/formoterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Asthma Bronchiale | Phase 3 | Status: COMPLETED